Page 17 - CORDIS

Oncology & Cancer

A small drop of blood for an ocean of information

Patient response to treatment—especially personalised medicine—can be very difficult to predict. To overcome this issue, the CHEMOS project has been advancing a new method for screening thousands of single-cell drug responses ...

Oncology & Cancer

CLL evolution under the microscope

How do initially benign forms of cancer evolve to become aggressive? In a quest to answer this long-standing question, an EU project has studied the growth and clonal evolution of chronic lymphocytic leukaemia (CLL)—a blood ...

Oncology & Cancer

Off-the-shelf T cell therapies for multiple myeloma

Although a source of much hope among 'multiple myeloma' (MM) patients, adoptive T cell therapies are still held back by expensive, lengthy, individual-tailored approaches. However, an EU-funded project is aiming to shake ...

Oncology & Cancer

Using miRNA to cure mature B cell neoplasia

Almost half of patients with mature B cell neoplasia are faced with the ineffectiveness of existing treatments. However, they may soon benefit from new therapeutic tools relying on miRNA—a small non-coding RNA molecule ...

Medical research

Growing new bone for more effective injury repair

Broken bones do not always repair fully, especially after major trauma such as a car accident. Complications can occur when the bone is broken in several places, the blood flow is reduced or infection sets in. Patients can ...

Diseases, Conditions, Syndromes

Martinican blood donors help shed new light on the Zika virus

Results from a large study of volunteer blood donors in Martinique during the 2016 Zika virus outbreak - which according to state health authorities affected 568 pregnant women - are now in. They provide a precise follow-up ...

page 17 from 40